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Glycosomes are peroxisome-related organelles that have been identified in kinetoplastids
and diplonemids. The hallmark of glycosomes is their harboring of the majority of the
glycolytic enzymes. Our biochemical studies and proteome analysis of Trypanosoma
cruzi glycosomes have located, in addition to enzymes of the glycolytic pathway,
enzymes of several other metabolic processes in the organelles. These analyses revealed
many aspects in common with glycosomes from other trypanosomatids as well as
features that seem specific for T. cruzi. Their enzyme content indicates that T. cruzi
glycosomes are multifunctional organelles, involved in both several catabolic processes
such as glycolysis and anabolic ones. Specifically discussed in this minireview are
the cross-talk between glycosomal metabolism and metabolic processes occurring in
other cell compartments, and the importance of metabolite translocation systems in
the glycosomal membrane to enable the coordination between the spatially separated
processes. Possible mechanisms for metabolite translocation across the membrane are
suggested by proteins identified in the organelle’s membrane—homologs of the ABC
and MCF transporter families—and the presence of channels as inferred previously from
the detection of channel-forming proteins in glycosomal membrane preparations from the
related parasite T. brucei. Together, these data provide insight in the way in which different
parts of T. cruzi metabolism, although uniquely distributed over different compartments,
are integrated and regulated. Moreover, this information reveals opportunities for the
development of drugs against Chagas disease caused by these parasites and for which
currently no adequate treatment is available.
Keywords: trypanosomes, glycosomes, peroxisomes, glycolysis, metabolic networks, metabolite transport,
biogenesis, drug discovery
INTRODUCTION
Like other kinetoplastids, Trypanosoma cruzi contains peroxisome-related organelles called
glycosomes (Figures 1A–D). Peroxisomes constitute a family of organelles that are present in all
superphyla of eukaryotes. Despite their diversity in protein content and size, these organelles are
homologous and share important features of their biogenesis and morphology and some functions
(1). Glycosomes are authentic members of this family, but characterized by containing enzymes of
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FIGURE 1 | (A–D) Ultrastructure of Trypanosoma cruzi epimastigote form showing glycosomes (G) and their proximity to other cell structures, especially the
kinetoplast (K) and mitochondrial branches (M). Glycosomes are also seen close to reservosomes (R); N, nucleus. (B,C) Are insets that show areas of (A) with higher
magnification. Cells were processed to transmission electron microscopy as follows. Protists were fixed for 1 h in 2.5% type II glutaraldehyde (Sigma, Missouri, USA)
diluted in 0.1M cacodylate buffer (pH 7.2). Then, they were washed twice in cacodylate buffer and post-fixed (1% osmium tetroxide, 0.8% potassium ferrocyanide,
5mM calcium chloride diluted in 0.1M cacodylate buffer) for 1 h. After fixation, samples were washed in cacodylate buffer, dehydrated in a graded series of acetone
solutions (50%, 70%, 90%, and two exchanges of 100% acetone) for 10min each step, and embedded in Polybed resin. Ultrathin sections were stained with 5%
uranyl acetate for 45min and lead citrate for 5min before observation in a Jeol 1200ex operating at 80 kV. (E) T. cruzi contains multiple glycosomes distributed
throughout the cell body as demonstrated by fluorescent puncta in transgenic epimastigotes and metacyclic trypomastigotes expressing green fluorescent protein
(GFP) containing a C-terminal PTS1 (-SKL) to target it to glycosomes.
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the glycolytic and gluconeogenic pathways. In some cases, such
as Trypanosoma brucei living in the mammalian bloodstream,
glycolytic enzymes may even comprise over 90% of the
glycosomal protein content. Probably, the common ancestor of
the Kinetoplastea and Diplonemida sequestered these enzymes in
their peroxisomes (Gualdrón-López et al., 2012a; Gabaldón et al.,
2016; Morales et al., 2016).
Trypanosomatids possess multiple small glycosomes.
Approximately 60–65 of these organelles with an average
diameter of 0.27µm have been reported for bloodstream-form
T. brucei, distributed throughout the cell body, often in clusters,
with the number increasing to ∼120 during parasite growth up
to cell division (Opperdoes et al., 1984; Tetley and Vickerman,
1991; Hughes et al., 2017), whereas 50 glycosomes have been
found in different life-cycle stages of T. cruzi (Soares and de
Souza, 1988; Soares et al., 1989) (Figure 1E). Importantly,
many of the glycosomal enzymes, as well as their sequestering
inside the organelles have been shown to be essential for the
viability of different trypanosomatids, rendering the organelles
promising targets for new drugs to be developed (Galland
and Michels, 2010; Barros-Alvarez et al., 2014; Dawidowski
et al., 2017). In this minireview, we will highlight some recent
findings about glycosomes, particularly from T. cruzi. More
detailed information about glycosomes can be found elsewhere
(Gualdrón-López et al., 2012a; Barros-Alvarez et al., 2014;
Allmann and Bringaud, 2017).
PROTEOME OF T. CRUZI GLYCOSOMES
The proteome of T. cruzi glycosomes has recently been
determined for the organelles isolated from cultured
epimastigotes (Acosta et al., 2019). Many enzymes previously
identified in glycosomes of T. brucei (Vertommen et al.,
2008; Güther et al., 2014) and Leishmania spp. (Jardim et al.,
2018) were also detected in the T. cruzi organelles: enzymes
involved in glycolysis and gluconeogenesis with their auxiliary
branches from phosphoenolpyruvate (PEP) comprising pyruvate
phosphate dikinase (PPDK) and enzymes of the succinate
production/utilization pathway, the pentose-phosphate
pathway (PPP), biosynthesis of sugar-nucleotides, purines,
and pyrimidines, sterols and ether-lipids and β-oxidation of
fatty acids as well as enzymes involved in detoxification of
oxygen radicals (Figure 2). Interestingly, also detected were
enzymes for two possible novel routes for the reoxidation of the
glycolytically produced NADH. The first route might involve
a D-isomer specific 2-hydroxyacid dehydrogenase (HADH);
this enzyme might catalyze the reduction of the pyruvate
to lactate, whereas the enzymes for the second route are a
putative aldehyde dehydrogenase (ALDH) that could reduce and
decarboxylate pyruvate to acetaldehyde and an oxidoreductase
(alcohol dehydrogenase, ADH) for the NADH-dependent
reduction of acetaldehyde to ethanol (see also Figure 1 in Acosta
et al., 2019). However, functional studies to prove these routes
remain to be performed. Further identified, and characterized
by our group were several enzymes previously reported to
be present in T. cruzi but absent from T. brucei, such as a
glucokinase (GlcK), galactokinase (GALK) and a unique form
of phosphoglycerate kinase (PAS-PGK) with at its N-terminus
a PAS domain, known to possess signaling and regulatory
functions (Cáceres et al., 2007; Rojas-Pirela et al., 2018; Acosta
et al., 2019).
Sterol synthesis is an essential metabolic process for T. cruzi
and Leishmania spp. These trypanosomatids produce a special
class of these lipids, including ergosterol and other C-24
methylated sterols, which are required for growth and viability of
the parasites, but are absent from mammalian host cells (Soares
and de Souza, 1991; Urbina, 1997). Previously, it has been shown
that various enzymes of sterol synthesis in T. brucei and L. major
are present in multiple intracellular compartments, including
glycosomes (Carrero-Lérida et al., 2009). Various enzymes of
the pathway were also detected in our proteomic analysis of
T. cruzi glycosomes (Figure 2) (Acosta et al., 2019). Because of
the unique aspects of the process in these parasites, several of
its enzymes are being considered as a drug target (reviewed in
de Souza and Fernandes-Rodrigues, 2009; Buckner and Urbina,
2012).
INTEGRATION OF GLYCOSOMES IN
OVERALL T. CRUZI METABOLISM
Although glycosomes contain an extensive metabolic network,
for most pathways only parts are present in the organelles
(Figure 2). For glycolysis and gluconeogenesis the majority
of the enzymes are compartmentalized, whereas for other
pathways, such as the pentose-phosphate metabolism,
purine salvage and biosynthesis of pyrimidines and ether
lipids only some enzymes were detected in the organelles
(Acosta et al., 2019). Moreover, enzymes showed often a
dual distribution over glycosomes and cytosol, either due
to partial compartmentalization (e.g., Concepción et al.,
1999) or represented by distinct isoenzymes (e.g., Barros-
Álvarez et al., 2014). This spatial organization of pathways
implies that glycosomal metabolism is firmly embedded
in the trypanosomatid’s overall metabolism and that many
metabolites that serve as substrates or products of glycosomal
metabolism have to cross the membrane to connect them
to the cytosolic parts of the pathways or for their further
metabolism in other pathways located in different cellular
compartments such as cytosol or mitochondrion. A well-
studied example is the last part of the glycolytic pathway
where either 1,3-bisphosphoglycerate or 3-phosphoglycerate
exits glycosomes to the cytosol where it is converted via PEP
to pyruvate by pyruvate kinase (PYK) that is then in part
metabolized by pyruvate dehydrogenase and the tricarboxylic
acid cycle in the mitochondrion. Alternatively, PEP enters the
glycosomes for the production of succinate or pyruvate by
the auxiliary branches of the glycolytic pathway mentioned
above (Acosta et al., 2004). In addition, the succinate producing
branch has a cytosolic shunt involving fumarate hydratase.
The distribution of fluxes through these different pathways
and the concomitant translocation of metabolites across the
glycosomal membrane seem to be controlled by the requirement
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FIGURE 2 | Diagrammatic representation of the glycosomal proteome of T. cruzi epimastigotes. Proteins involved in metabolic pathways, solute transport and
glycosome biogenesis are represented in circles. Lines represent connections between different processes by exchange of metabolites. Glycolysis: HXK,
hexokinase; GlcK, glucokinase; PGI, phosphoglucose isomerase; PFK, phosphofructokinase; ALD, aldolase; TIM, triosephosphate isomerase; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; PGK, phosphoglycerate kinase. Auxiliary to glycolysis and gluconeogenesis: G3PDH, glycerol-3-phosphate
dehydrogenase; GK, glycerol kinase; PEPCK, phosphoenolpyruvate carboxy kinase; MDH, malate dehydrogenase; FH, fumarate hydratase; FRD, NADH-fumarate
reductase; PPDK, pyruvate phosphate dikinase; ALDH, aldehyde dehydrogenase; HADH, D-isomer specific 2-hydroxyacid dehydrogenase-protein; ALADH, alanine
dehydrogenase; ADH, alcohol dehydrogenase; AK, adenylate kinase; ArgK, arginine kinase. Other sugar metabolism: GALK, galactokinase; USPase, UDP-sugar
pyrophosphorylase; GALE, UDP-galactose 4-epimerase; UGPUT, UTP-glucose-1-phosphate uridylyltransferase; PMM, phosphomannomutase-like protein; GalO,
L-galactonolactone oxidase; PMI, phosphomannose isomerase; GNPI, glucosamine-6-phosphate isomerase; NagA, N-acetylglucosamine-6-phosphate
deacetylase-like protein; GlyK, glycerate kinase; GarR, 2-hydroxy-3-oxopropionate reductase; DHAK, dihydroxyacetone kinase; DHAS, dihydroxyacetone synthase.
Pentose-phosphate pathway: HPE, D-hexose-6-phosphate-1-epimerase; G6PDH, glucose-6-phosphate dehydrogenase; LAC, lactonase; 6PGD,
6-phosphogluconate dehydrogenase; RPI, ribulose-5-phosphate isomerase; R5PE, ribulose-5-phosphate epimerase; TKT, transketolase; SBTA,
sedoheptulose-1,7-phosphate transaldolase; TAL, transaldolase; SBPase, sedoheptulose-1,7-bisphosphatase; RK, ribulokinase; RBK, ribokinase.
Gluconeogenesis: FBPase, fructose-1,6-bisphosphatase. Ether-lipid synthesis: FAR, fatty-acyl-CoA reductase; ADHAPS, alkyl-DHAP synthase; DHAPAT, DHAP
acyltransferase; AGPO, 1-alkyl G3P(NADP+)-oxidoreductase. β-oxidation: FACS, fatty-acyl CoA synthetase; ACAD, acyl-CoA dehydrogenase; ECH, enoyl-CoA
hydratase; HADH, 3-hydroxyacyl-CoA dehydrogenase; 3-KAT, 3-ketoacyl-CoA thiolase; TECI, 3,2-trans-enoyl-CoA isomerase; ECI, enoyl-CoA isomerase; FAE, fatty
acid elongase. Sterol and isoprenoid synthesis: HMCS, 3-hydroxy-3-methylglutaryl CoA synthase; HMCR, 3-hydroxy-3-methylglutaryl CoA reductase; MVK,
mevalonate kinase; IDI, isopentenyl-diphosphate delta-isomerase; SQS, squalene synthase; SM, squalene monooxygenase; LDM, lanosterol 14-alpha-demethylase;
SD, NAD(P)-dependent steroid dehydrogenase protein; SMT, sterol 24-C-methyltransferase; SI, C-8 sterol isomerase; 24-SR, sterol C-24 reductase; 3O5-SDH,
3-oxo-5-alpha-steroid 4-dehydrogenase. Purine salvage: NPase, nucleoside phosphorylase; APRT, adenine phosphoribosyltransferase; PRPPS, phosphoribosyl
pyrophosphate synthetase; AMPD, AMP deaminase; IMPDH, inosine-5’-monophosphate dehydrogenase; GMPR, guanosine monophosphate reductase; HGPRT,
hypoxanthine-guanine phosphoribosyltransferase; PPM, phosphopentomutase. Pyrimidine synthesis: OPRTase, orotate phosphoribosyltransferase; PRPPS,
phosphoribosylpyrophosphate synthetase; OPDC, orotidine-5-phosphate decarboxylase. Amino acid metabolism: HAL, histidine ammonia-lyase; IPP,
imidazolonepropionase; ProDH, proline dehydrogenase; P5CR, pyrroline-5-carboxylate reductase; T3DH, L-threonine-3-dehydrogenase; TDase, threonine
dehydratase-like, OVDH, 2-oxoisovalerate dehydrogenase alpha subunit. Defense against oxidative stress: Argase, arginase; IDH, isocitrate dehydrogenase; GP,
glutathione peroxidase-like protein; TR, trypanothione reductase; SOD, iron superoxide dismutase; AOD, acetylornithine deacetylase-like; Cyt B5 red, Cytochrome-B5
reductase; THR, thiol-dependent reductase 1. Other enzymes: AKR, aldo-keto reductase; NA, nicotinamidase. Membrane (associated) proteins: PEX, peroxin;
GIM5A, glycosomal integral membrane protein 5. Pore-forming protein: PEX11. Solute transporters: MCF, mitochondrial carrier family protein; GAT, ABC
transporter. Membrane-associated enzyme: CAT, carnitine/choline O-acyltransferase. For a detailed assessment of the results and a presentation of glycosomal
metabolic pathways (see Acosta et al., 2019).
for maintaining an intraglycosomal balance between both ATP
production and consumption and NAD+/NADH reduction and
oxidation (Acosta et al., 2004).
This integration of glycosomal pathways in the trypanosome’s
overall metabolism has implications for the mechanisms by
which metabolites cross the glycosomal membrane and may
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provide clues about the function of the organelles and the
selective force that led to its evolution. These aspects will be
discussed in the next sections.
SOLUTE TRANSLOCATION ACROSS THE
GLYCOSOMAL MEMBRANE
Studies of metabolite translocation across the glycosomal
membrane have been predominantly performed for T. brucei.
These studies revealed a similar situation as for peroxisomes of
different organisms: the existence of two groups of transporters,
half-size ABC transporters and proteins of the Mitochondrial
Carrier Family (MCF), as well as pore-forming proteins
(reviewed in Gualdrón-López et al., 2013). Based on the situation
in peroxisomes and some preliminary experiments with T. brucei
glycosomes (Visser et al., 2007; Igoillo-Esteve et al., 2011;
Antonenkov and Hiltunen, 2012; Gualdrón-López et al., 2012b),
it was proposed that the ABC and MCF transporters are
involved in the import of large molecules like fatty-acids and
cofactors (ATP, NAD+, etc.) into glycosomes, while smaller
molecules, with an estimated Mr of approximately 400 Da,
such as glycolytic intermediates and inorganic ions pass through
pores (Gualdrón-López et al., 2013). It has recently been shown
in yeast that peroxin PEX11, previously identified as a factor
involved in division and proliferation of peroxisomes from
mammals, yeasts and plants, acts also as a protein in the
formation of pores conducting solutes with Mr below 300–
400 Da (Mindthoff et al., 2016). Trypanosomatid glycosomal
membranes do contain PEX11 homologs. An additional
pore-forming protein, Pxmp2, has been detected in mouse
peroxisomes and functionally characterized. Electrophysiological
experiments suggested that additional pore-forming proteins are
also likely present in glycosomes but remain to be identified
(Gualdrón-López et al., 2012b).
Proteomic analysis has revealed in T. brucei glycosomes other
hypothetical membrane proteins which may be involved in
translocation of other, notably large solutes, for example sugar-
nucleotides, however this remains to be determined (Güther
et al., 2014). The proteome of T. cruzi glycosomes showed
a very similar repertoire of membrane-associated (candidate)
transporters as in T. brucei (Acosta et al., 2019). Intriguingly, in
glycosomes of both T. brucei and T. cruzi a putative carnitine
O-acyltransferase (CAT) was found (Güther et al., 2014; Acosta
et al., 2019). However, no acyl-carnitine translocase was detected
that would suggest import of acyl-carnitines as alternative to that
of acyl-CoAs via the ABC transporter GAT1 (Igoillo-Esteve et al.,
2011) for providing acyl-CoAs for β-oxidation and ether-lipid
biosynthesis. This situation seems reminiscent to mammalian
and yeast peroxisomes for which it has been suggested that
its CAT serves to produce acyl-carnitines from acyl-CoA
derivatives that have been shortened by β-oxidation within the
organelles. Carnitine esters are smaller than the corresponding
CoA derivatives and may exit through the channels to the cytosol
where they are converted back to free carnitine and acetyl(acyl)-
CoAs by cytosolic and mitochondrial CATs (Antonenkov and
Hiltunen, 2012). For a more detailed discussion about solute
translocation across glycosomal membranes and transporters, see
references (Gualdrón-López et al., 2013; Acosta et al., 2019).
The energization of metabolite transport through peroxisomal
and glycosomal membranes has been a matter of debate for
several years. It was clearly established that fatty-acid transport
is mediated by ABC transporters driven by ATP hydrolysis
at the cytosolic face of the organellar membrane (Wanders
and Tager, 1998; Visser et al., 2007; Igoillo-Esteve et al.,
2011). In contrast, data about the possible involvement of
H+ or ion gradients to drive translocation of other solutes
were contradictory (reviewed in Wanders and Tager, 1998;
Antonenkov and Hiltunen, 2006). Several previous studies, using
either radioactively labeled probes, often weak acids or bases,
or fluorescent compounds containing a peroxisomal-targeting
sequence (PTS), or by 31P-NMR, claimed the existence of a pH
gradient across the membrane of these organelles. However, in
some cases an intraorganellar matrix with alkaline pH compared
to the cytosol was reported, while in other cases it was considered
acidic. Furthermore, H+ or ion pumps or transporters for small
solutes have so far never unambiguously been identified in
any peroxisomal membrane (Antonenkov and Hiltunen, 2006,
2012; Visser et al., 2007). Recently, a fluorescein-tagged peptide
containing a PTS has also been used in studies with procyclic T.
brucei (Lin et al., 2013, 2017). The authors reported a slightly
acidic intraglycosomal pH that was regulated independently
from the cytosolic pH in cells subjected to variable nutrient
availability. Based on inhibition studies, V-ATPases and Na+/H+
exchangers were invoked. However, no specific H+ or ion pumps
have been identified thus far in glycosomes either, except one
report of a V-ATPase in the proteome of bloodstream forms
but not procyclic T. brucei (Colasante et al., 2006). Careful
interpretation of proteome data about peroxisomes/glycosomes
is required because it should be realized that these organelles,
despite their high buoyant density, are notoriously difficult to
isolate in intact form and free of contaminants from other
organelles, because of their apparent high fragility (Antonenkov
and Hiltunen, 2006) and, as has become apparent in recent
years, their physical interactions with other organelles such as ER
and mitochondria (Fransen et al., 2017; Kim, 2017; Shai et al.,
2018). To obtain a high-confidence proteome of these organelles
requires specific methods such as their enrichment by epitope
tagging as done by Güther et al. (2014). Moreover, as has been
argued (e.g., Antonenkov and Hiltunen, 2006, 2012), it is not
clear how the presence of non-selective (with regard to anions
vs. cations) transmembrane channels allowing permeation of
solutes and ions with Mr < ∼400 Da could be compatible with
the active creation of pH gradients and membrane potentials
across peroxisomal/glycosomal membranes. Additionally, the
notion of a specific intraglycosomal pH is not obvious. Most
peroxisomes are small spherical organelles; for bloodstream-form
T. brucei an average diameter of 0.27µm has been reported
(Opperdoes et al., 1984; Tetley and Vickerman, 1991), with those
in other trypanosomatids having comparable dimensions. This
corresponds with a volume of 0.0108 µm3, implying that, at pH
7, on average, a glycosome would contain only 0.65 free H+
(i.e., using the definition of pH and Avogadro’s number: 10−7
× 6.022 × 1023 × 0.0108 × 10−15 free H+/glycosome). The
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addition of a single free H+ would result in an intraglycosomal
pH drop of ∼0.4. It is important to realize that such calculations
provide averaged values: averaged in time and space, over the
total number of glycosomes in a trypanosome. Establishment
of a pH is a dynamic process, involving metabolic reactions
and the continuous protonation/deprotonation of many groups
(of proteins, metabolites, phospholipids, etc.). One may thus
wonder if the apparent response of the probes is affected by
specific properties of the organelles, such as the high density
of proteins with relatively high pI values—both considerably
higher than in cytosol, the relatively high membrane/matrix
ratio and/or the presence of inorganic polyphosphate (Negreiros
et al., 2018). Because of the existence of non-selective, relatively
large pores in the membrane, it seems realistic to consider
that the cytosol and the matrix of the glycosomes form a
continuum with regard to H+ and inorganic ions. Nonetheless,
the higher density of proteins in the glycosomal matrix compared
to the cytosol, the relatively high pI values of glycosomal
enzymes and the presence of pores may be responsible for the
creation of a Donnan equilibrium of H+, inorganic ions and
small solutes (metabolites) across the membrane, i.e., slightly
different concentrations on both sides, responsible for a (small)
membrane potential and/or pH gradient. Furthermore, as argued
by Antonenkov and Hiltunen (2006), the inconsistency in results
obtained in different experiments for the intraperoxisomal pH
may indicate it is a dynamic parameter depending on the
physiological conditions in the cell. This is in line with the
notion that some pH gradient across the peroxisomal membrane
may be the created—transiently or constantly—by the Donnan
equilibrium. Membrane-potential or pH-sensitive probes may
thus respond to such differences (Gualdrón-López et al., 2012b;
discussed in Antonenkov and Hiltunen, 2012).
BIOGENESIS OF GLYCOSOMES
Glycosome biogenesis has been studied in detail in T. brucei
and to a lesser extent in Leishmania spp. (reviewed in Galland
and Michels, 2010; Gualdrón-López et al., 2013; Haanstra et al.,
2016; Bauer and Morris, 2017). However, few studies have
been devoted to this process in T. cruzi. The biogenesis occurs
in a similar way as that of peroxisomes in other eukaryotes,
involving mostly homologous proteins called peroxins or PEX
proteins. Peroxins are involved in different stages of peroxisome
formation, such as the posttranslational insertion of membrane
proteins and import of matrix proteins. The organelles can be
formed by two mechanisms: (i) budding from special parts
of the endoplasmic reticulum (ER) after insertion of some
(or all) peroxisomal membrane proteins (PMPs), followed by
fusion with pre-existing peroxisomes and maturation involving
matrix protein import, or (ii) PMPs and matrix proteins are
directly sorted to existing peroxisomes. Lipids for growing and
proliferating peroxisomes are provided by the vesicular transport
from the ER, but may also be delivered via not yet well-
studied non-vesicular routes involving contact sites between
the organelles and the ER (Jansen and Van der Klei, 2019).
The import of peroxisomal and glycosomal matrix proteins
can occur by translocation of fully folded proteins and even
multimeric complexes (Yang et al., 2018). This process starts
in the cytosol by recognition of a peroxisomal-targeting signal
(PTS), in most cases either a sequence motif at the C-terminus
(PTS1) or one near the N-terminus (PTS2), in newly synthesized
proteins by either of two cytosolic receptors of the peroxin
family. The receptor-ligand complexes dock subsequently at the
peroxisomal membrane where a series of interactions between
different peroxins take place, culminating in the formation of a
large transient pore through which the receptor-matrix protein
complexes are imported into the organelles. The receptors are
cycled back to the cytosol by an ubiquitin- and ATP-dependent
mechanism to perform more rounds of import (Galland and
Michels, 2010; Meinecke et al., 2010; Gualdrón-López et al.,
2013).
A considerable number of T. brucei homologs of mammalian
and yeast peroxins involved in PMP insertion and matrix protein
import have been identified and characterized, and shown to
be involved in glycosome biogenesis (Kalel et al., 2015, 2019;
Banerjee et al., 2019; and reviewed in Galland and Michels,
2010; Gualdrón-López et al., 2013). Orthologous genes have been
detected in the genome of T. cruzi and several of the proteins in
its glycosomal proteome (Acosta et al., 2019).
POLYPHOSPHATES IN GLYCOSOMES
Docampo and coworkers have shown that trypanosomes
synthesize and store inorganic polyphosphate (polyP) in their
acidocalcisomes. Recently, they also reported the presence of
important amounts of long-chain polyP in the nucleolus and
glycosomes of T. brucei and T. cruzi, where it interacts with
proteins. In glycosomes it displays affinity to several enzymes
of carbon metabolism (Negreiros et al., 2018). The reason for
the presence of polyP in glycosomes remains to be established.
Maybe it acts as a negatively charged scaffold in the creation
of an assembly of the intraglycosomal enzymes which have
generally a high pI and are present at high density (Misset
et al., 1986). This notion is supported by the observation
that glycosomal proteins remain largely packed in a complex
when the membrane of purified glycosomes is dissolved by
Triton-X-100 or permeabilized by digitonin; the complex is only
disrupted at elevated ionic strength (Misset andOpperdoes, 1984;
Misset et al., 1986). Alternatively or additionally, polyP may
play a regulatory role in the enzyme activities, like PPi that
has been shown to inhibit the activities of several glycosomal
enzymes, such as T. cruzi, L. mexicana and one of the T.
brucei hexokinases (HKs) (Cáceres et al., 2003; Pabón et al.,
2007; Chambers et al., 2008) and T. cruzi PEP carboxykinase
(Acosta et al., 2004), but this has not yet been tested for
polyP. In addition, PPi plays a role as substrate or product
in several reactions within glycosomes (Acosta et al., 2019).
Interestingly, when a yeast exopolyphosphatase was expressed in
T. brucei glycosomes, the intraglycosomal polyP levels decreased,
while the glycolytic flux was also affected and the parasites
became more susceptible to oxidative stress (Negreiros et al.,
2018). Furthermore, the T. brucei genome contains genes
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encoding five proteins belonging to the Nudix superfamily,
comprising enzymes that hydrolyse a wide range of organic
pyrophosphates. Two of them, TbNH2 and TbNH4 possess
polyP exopolyphosphatase and endopolyphosphatase activities,
respectively. While TbNH4 localizes to the cytosol and nucleus,
TbNH2 was detected in the glycosomes (Colasante et al., 2006;
Güther et al., 2014; Cordeiro et al., 2019). TbNH2 has the
tripeptide –SSI at its C-terminus, a possible PTS1 (Colasante
et al., 2006), suggesting that the protein plays a role in polyP
homeostasis in the organelles. However, no Nudix hydrolase
was found in the glycosomal proteome of T. cruzi epimastigotes
(Acosta et al., 2019). The T. cruzi genome encodes a TbNH2
ortholog (60% identical, 80% similar), but with a somewhat
different C-terminal sequence (–SAL or –DSI, dependent on
the strain) that may not be able to sort the protein to the
organelles. Therefore, further research is required to establish
if Nudix proteins are involved in glycosomal polyP hydrolysis.
Whether polyP serves as glycosomal storage of PPi that is
known to regulate the activity of several glycosomal enzymes
seems questionable if PPi may easily pass through the pores in
the membrane.
GLYCOSOMAL REPROGRAMMING
DURING DIFFERENTIATION OF
TRYPANOSOMES
T. cruzi, like other dixenous trypanosomatid parasites,
undergoes an elaborate life cycle involving extracellular
replicative epimastigotes in the triatomine digestive tube,
non-replicative extracellular metacyclic and bloodstream
trypomastigotes in the insect and mammalian host, respectively,
and replicative amastigotes intracellularly in the cytosol of
the mammalian cells. The different developmental stages
differ importantly in morphology, but also in metabolism to
adapt to the large nutritional conditions encountered in the
different niches (Maugeri et al., 2011; Barisón et al., 2017;
Avila et al., 2018; Marchese et al., 2018; Mattos et al., 2019).
Since glycosomes harbor many enzymes of intermediary
metabolism as well as enzymes of other metabolic processes
which are differentially expressed, glycosomal metabolism has to
undergo reprogramming.
Indeed, levels and activities of glycosomal enzymes differ
importantly between bloodstream-form and procyclic T.
brucei (Hart et al., 1984). As for T. cruzi, a comparison of
the proteome of glycosomes from epimastigotes harvested
from the exponential and stationary growth phase, which,
respectively, rely primarily on glucose and amino acids as
carbon and energy source (Barros-Alvarez et al., 2014; Barisón
et al., 2017), showed only small qualitative differences in the
repertoire of both intraglycosomal enzymes and proteins in
the glycosomal membrane (Acosta et al., 2019). It remains to
be determined to what extent quantitative and/or qualitative
differences occur in the glycosomal proteome during in vivo
differentiation between the different life-cycle stages. Another
recent study, in which T. cruzi trypomastigotes were analyzed
before and after in vitro interaction with extracellular matrix
(ECM), provides further information to the question to what
extent quantitative and/or qualitative differences occur in the
glycosomal proteome during in vivo differentiation between
life-cycle stages (Mattos et al., 2019). Interactions with ECM
components are essential prior to the invasion of mammalian
host cells by T. cruzi. The authors reported important changes
in the cellular phosphoproteome of the trypomastigotes, notably
concerning proteins of carbon metabolism. A decrease of
phosphorylation was observed for the glycosomal enzymes
hexokinase (HK), phosphofructokinase (PFK) and PPDK,
the cytosolic PYK, 6-phosphofructo-2-kinase/fructose-2-
bisphosphatase (PFK2/FBPase2) and alanine transferase (ALT),
and PGK that is present in both compartments, whereas
phosphorylation of glycosomal fumarate reductase (FRD) was
increased. These changes correlated with a decrease of activities
of HK and PYK, as well as changes in the concentration of
various intermediates of carbon metabolism. Together, the
data indicate that phosphorylation of these enzymes, both
glycosomal and cytosolic, plays an important role to control
their activity and that the interaction of trypomastigotes with
ECM components serves as trigger for the cells to prepare for
intracellular life as amastigotes, by decreasing the glycolytic
activity through dephosporylation of the enzymes. Previously,
differential phosphorylation of proteins, including glycosomal
enzymes, has also been demonstrated when bloodstream-form
and procyclic T. brucei were compared (Urbaniak et al., 2013).
The mechanism by which the life-cycle stage dependent
glycosome reprogramming occurs has not yet been studied
in T. cruzi, but has been addressed in T. brucei and
Leishmania spp. (Hart et al., 1984; Mottram and Coombs,
1985; Colasante et al., 2006; Herman et al., 2008; Vertommen
et al., 2008; Brennand et al., 2011; Cull et al., 2014). Data
indicate that this reprogramming involves mainly degradation
of organelles containing the redundant enzyme repertoire
by pexophagy—i.e., the autophagy process characteristic for
peroxisome degradation—while new organelles are formed with
an enzyme content that is appropriate for the conditions to
be encountered by the new developmental form. Glycosomal
proteins are encoded by genes in the nucleus and regulation
of the glycosomal enzyme content is thought to occur via
mechanisms controlling both expression of genes in general
and that of genes for metabolic enzymes in particular in
trypanosomes, i.e., mainly post-transcriptionally (Kafková et al.,
2018; Clayton, 2019). Furthermore, it is feasible that the
relative abundance of different proteins in the organelles is
also dependent on differential rates of their import, since
the sequence motif variants of PTS exhibit different import
efficiencies (Sommer et al., 1992).
It has been proposed that compartmentalization of glycolysis
and other core metabolic processes in glycosomes has evolved
as a mechanism by which kinetoplastid organisms can adapt, by
the turnover of the organelles through pexophagy and synthesis
of new ones, their metabolism efficiently to large and sudden
environmental changes as they encounter during their life cycle,
possibly facilitating the emergence of a parasitic life style in many
of these organisms (Herman et al., 2008; Brennand et al., 2011;
Gualdrón-López et al., 2012a; Gabaldón et al., 2016).
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Furthermore, in T. brucei, glycosomes have been shown
to play a role in the parasite’s differentiation. The organelles
contain the serine/threonine phosphatase PIP39 with a PTS1
(–SRL) at its C-terminus. This protein is part of a protein
phosphatase cascade that regulates the differentiation of the non-
replicating short-stumpy bloodstream forms to the proliferating
procyclic forms in the tsetse fly (Szöör et al., 2010). In the short-
stumpy forms in the bloodstream, PIP39 is kept inactivated and
dephosphorylated in the cytosol, by interaction with tyrosine
phosphatase PTP1 at a periflagellar pocket location, closely
associated with a flagellar pocket ER contact site, coincident with
the location of a regulator of stumpy-form transcripts, REG9.1
(Szöör et al., 2019). When the parasites are taken up in the fly, the
lowered temperature at∼20◦C triggers an elevated expression of
PAD proteins—members of the Major Facilitator Superfamily,
most related to carboxylate transporters in other organisms—
in the trypanosome’s plasma membrane, allowing the uptake
of citrate/cis-aconitate. This leads to disruption of the PTP1-
PIP39 complex, PIP39 becoming phosphorylated and active, and
relocated to glycosomes, whereas PTP1 becomes dispersed to a
non-glycosomal, possibly cytosolic location. Szöör et al. (2019)
proposed that the location of the “stumpy regulatory nexus”
(STuRN) containing the PTP1-PIP39 complex and REG9.1 is
similar to that of the pre-peroxisomal vesicles budding from the
ER. After disruption of the complex, PIP39 is sequestered into
glycosomes newly formed at this site. STuRN will so coordinate
life-cycle differentiation with reprogramming of the glycosomal
metabolic machinery.
T. cruzi contains a TbPIP39 homolog (59% identical, 77%
similar, and also containing the PTS1 –SRL) that was detected in
the proteome of epimastigote glycosomes (Acosta et al., 2019), as
well as a TbPTP1 homolog (61% identical, 75% similar) (Szöör
et al., 2006). It will be interesting to determine if PIP39 and
PTP1 play a similar role, upon being triggered by a species-
specific signal, in life-cycle differentiation of T. cruzi as they do
in T. brucei.
CONCLUSIONS
Glycosomes are authentic members of the peroxisome-organelle
family, but have as distinguishable feature the sequestering
of enzymes of glycolysis and other core processes of carbon
metabolism. Although glycolysis is important, and in some
trypanosomatid life-cycle stages essential for ATP production,
there are several reasons why these organelles should not be
considered as the cells “ATP factories” or as “energy-transducing
organelles” comparable to mitochondria. First, ATP production
and hydrolysis by all processes together—catabolic and anabolic
ones—within the organelles seem to be kept in balance, net
ATP production occurs outside the organelles. Contrary to
mitochondria, there is no evidence for ATP delivery, in exchange
for ADP, from the matrix to the cytosol. Also intraglycosomal
NAD+ reduction and NADH oxidation are in balance; excess
reducing power is transferred to the cytosol by a shuttle and from
there to the mitochondrion. In contrast, mitochondrial shuttles
serve to transfer electrons from cytosolic NADH to the organellar
NAD+, mainly for subsequent oxidative phosphorylation.
Translocation of adenine nucleotides and nicotine adenine
nucleotides by transporters across the glycosomal membrane
has not yet been demonstrated, but possibly occurs to provide
cofactors, after their synthesis in the cytosol, to proliferating
organelles, rather than to serve for balancing the stoichiometry
of intraglycosomal metabolic processes. Second, there is no
evidence that peroxisomal membranes are involved in energy
transduction, like the inner-mitochondrial membrane derived
from the cytoplasmic membrane of the ancestral endosymbiotic
bacterium. Peroxisomal membranes originate mainly from the
ER and incorporate proteins that form pores allowing the
passage of molecules up to ∼400 Da, but not the larger
ATP, NAD(H) and other cofactors. It is therefore unlikely
that they form a permeability barrier for H+ and inorganic
ions. Import and efflux of metabolites occurs probably by
diffusion through the pores and is dependent on their gradients,
rather than transmembrane H+ or ion gradients, and on the
control of the fluxes by the enzymes within and outside the
organelles. Moreover, the notion of a separate matrix pH
for small organelles as glycosomes is doubtful. Glycosomal
function(s) should therefore rather be sought in other aspects
such as assembly of enzymes in functional, efficient complexes
and/or the coordinated turnover of major units of metabolic
machinery by autophagy and biogenesis of the organelles
during life-cycle differentiation (Herman et al., 2008; Brennand
et al., 2011; Gualdrón-López et al., 2012a; Gabaldón et al.,
2016).
An as yet unsolved question is how long-chain polyP is
sequestered within glycosomes. There are no indications for
its synthesis in these organelles. It is probably “piggyback”
imported in association with the positively charged matrix
proteins through the transient pores formed by peroxins which
have the ability to transport proteins, even when folded,
in multimeric form or with bound, large artificial ligands
(Häusler et al., 1996; Meinecke et al., 2010; Yang et al.,
2018).
Although the origin of peroxisomes and glycosomes is
unrelated to that of mitochondria, it is important to realize
that recent research has established contact sites, vesicular
traffic, coordinated proliferation, and sharing of physiological
functions between peroxisomes and mitochondria (Fransen
et al., 2017; Kim, 2017; Shai et al., 2018). This aspect requires
further study and has not yet been addressed for the organelles
in trypanosomatids.
Finally, although glycosomes are evolutionarily related
to peroxisomes, and share some functions, there are also
considerable differences in enzyme content and aspects of
their biogenesis. The large evolutionary distance between
human and trypanosomes has resulted in large differences
in the proteins involved. These differences, together with
the essentiality of glycosomes and several of its metabolic
processes make a variety of the trypanosomatid enzymes
and peroxins promising drug targets. Indeed, selective, potent
inhibitors of some glycosomal proteins have been developed
that interfere with metabolic processes like sterol biosynthesis
and glycosome biogenesis or function and kill the parasites
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(Buckner and Urbina, 2012; Barros-Alvarez et al., 2014;
Dawidowski et al., 2017).
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